Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Decline of Anti-SARS-CoV-2 IgG Antibody Levels 6 Months after Complete BNT162b2 Vaccination in Healthcare Workers to Levels Observed Following the First Vaccine Dose
Oktavija Đaković Rode, Kristian Bodulić, Sanja Zember, et al.
Vaccines (2022) Vol. 10, Iss. 2, pp. 153-153
Open Access | Times Cited: 28

Showing 1-25 of 28 citing articles:

Key Considerations during the Transition from the Acute Phase of the COVID-19 Pandemic: A Narrative Review
Piotr Rzymski, Maria Pokorska‐Śpiewak, Teresa Jackowska, et al.
Vaccines (2023) Vol. 11, Iss. 9, pp. 1502-1502
Open Access | Times Cited: 19
Longitudinal Assessment of BNT162b2- and mRNA-1273-Induced Anti-SARS-CoV-2 Spike IgG Levels and Avidity Following Three Doses of Vaccination
Jimmie Bullock, Thomas E. Hickey, Troy J. Kemp, et al.
Vaccines (2024) Vol. 12, Iss. 5, pp. 516-516
Open Access | Times Cited: 5
Evaluation of anti-SARS-CoV-2 RBD antibody response after booster dose of SpikoGen® in individuals with two previous doses of Sinopharm and its association with HLA-DR and -DQ alleles
Amir Hossein Hajijafary, Somayeh Malekmohammad, Awat Feizi, et al.
Human Immunology (2025) Vol. 86, Iss. 1, pp. 111227-111227
Closed Access
Immunity in SARS-CoV-2 Infection: Clarity or Mystery? A Broader Perspective in the Third Year of a Worldwide Pandemic
Katarzyna Kapten, Krzysztof Orczyk, Elżbieta Smolewska
Archivum Immunologiae et Therapiae Experimentalis (2023) Vol. 71, Iss. 1
Open Access | Times Cited: 10
The Levels of Anti-SARS-CoV-2 Spike Protein IgG Antibodies Before and After the Third Dose of Vaccination Against COVID-19
Małgorzata Łysek-Gładysińska, Magdalena Starz, Agnieszka Borowiec-Sęk, et al.
Journal of Inflammation Research (2023) Vol. Volume 16, pp. 145-160
Open Access | Times Cited: 9
Key Essentials during the Transition from the Acute Phase of the COVID-19 Pandemic
Piotr Rzymski, Maria Pokorska‐Śpiewak, Teresa Jackowska, et al.
(2023)
Open Access | Times Cited: 9
Evaluation of SARS-CoV-2 anti-Spike antibody levels and breakthrough infection risk among vaccinated adults in North Lebanon
Dalal Nour, Mohamad Bachar Ismail, Marwan Osman, et al.
PLoS ONE (2024) Vol. 19, Iss. 5, pp. e0302579-e0302579
Open Access | Times Cited: 2
Kinetics of SARS-CoV-2 Serum Antibodies Through the Alpha, Delta, and Omicron Surges Among Vaccinated Health Care Workers at a Boston Hospital
Maura C Dodge, Lei Ye, Elizabeth R. Duffy, et al.
Open Forum Infectious Diseases (2023) Vol. 10, Iss. 7
Open Access | Times Cited: 7
Quantitative Synthesis of Factors Associated with COVID-19 Vaccine Acceptance and Vaccine Hesitancy in 185 Countries
Jerome Nyhalah Dinga, Severin Kabakama, Dieudonné Lemuh Njimoh, et al.
Vaccines (2023) Vol. 12, Iss. 1, pp. 34-34
Open Access | Times Cited: 7
SARS-CoV-2 spike protein antibody titers 6 months after SARS-CoV-2 mRNA vaccination among patients undergoing hemodialysis in Japan
Daisuke Kanai, Hiromichi Wakui, Tatsuya Haze, et al.
Clinical and Experimental Nephrology (2022) Vol. 26, Iss. 10, pp. 988-996
Open Access | Times Cited: 9
Durability of Humoral Responses after the Second Dose of mRNA BNT162b2 Vaccine in Residents of a Long Term Care Facility
Alessia Lai, Barbara Caimi, Marco Franzetti, et al.
Vaccines (2022) Vol. 10, Iss. 3, pp. 446-446
Open Access | Times Cited: 8
Immunogenicity of BNT162b2, BBIBP-CorV, Gam-COVID-Vac and ChAdOx1 nCoV-19 Vaccines Six Months after the Second Dose: A Longitudinal Prospective Study
Vladimir Petrović, Vladimir Vuković, Aleksandra Patić, et al.
Vaccines (2022) Vol. 11, Iss. 1, pp. 56-56
Open Access | Times Cited: 8
Slower Waning of Anti-SARS-CoV-2 IgG Levels Six Months after the Booster Dose Compared to Primary Vaccination
Sanja Zember, Kristian Bodulić, Nataša Cetinić Balent, et al.
Vaccines (2022) Vol. 10, Iss. 11, pp. 1813-1813
Open Access | Times Cited: 7
Assessment of immunoglobin G (spike and nucleocapsid protein) response to COVID-19 vaccination in Palestine
Imad Asmar, Omar Almahmoud, Khalid Yaseen, et al.
Clinical Epidemiology and Global Health (2023) Vol. 22, pp. 101330-101330
Open Access | Times Cited: 2
The Dynamics of Antibody Titres Against SARS-CoV-2 in Vaccinated Healthcare Workers: A Systemic Literature Review
Vilija Gurkšnienė, Tadas Alčauskas, Fausta Majauskaitė, et al.
Vaccines (2024) Vol. 12, Iss. 12, pp. 1419-1419
Open Access
Adverse Events and Immunogenicity of mRNA-Based COVID-19 Vaccine among Healthcare Workers: A Single-Centre Experience
Jolanta Sauserienė, Ida Liseckienė, Vitalija Neverauskė, et al.
Medicina (2022) Vol. 58, Iss. 3, pp. 441-441
Open Access | Times Cited: 3
How Protective are Antibodies to SARS-CoV-2, the Main Weapon of the B-Cell Response?
Stéphanie Pons, Fabrice Uhel, Eric Frapy, et al.
Stem Cell Reviews and Reports (2022) Vol. 19, Iss. 3, pp. 585-600
Open Access | Times Cited: 3
Reactogenicity and Peak Anti-RBD-S1 IgG Concentrations in Individuals with No Prior COVID-19 Infection Vaccinated with Different SARS-CoV-2 Vaccines
Lara Milevoj Kopčinović, Adriana Unić, Nora Nikolac, et al.
Laboratory Medicine (2023) Vol. 55, Iss. 2, pp. 162-168
Closed Access | Times Cited: 1
BNT162b2 Vaccination after SARS-CoV-2 Infection Changes the Dynamics of Total and Neutralizing Antibodies against SARS-CoV-2: A 6-Month Prospective Cohort Study
Jorge Hernández‐Bello, José Julio Sierra-García-de-Quevedo, José Javier Morales‐Núñez, et al.
Vaccines (2023) Vol. 11, Iss. 6, pp. 1127-1127
Open Access | Times Cited: 1
Evolution of Acquired Humoral Immunity after Full Vaccination against SARS-CoV-2. IgG Levels in Healthcare Workers at 6 and 9 Months
María Victoria Delicado Useros, Esther Navarro-Rodenas, Indalecio Miguel Sánchez Onrubia, et al.
World Journal of Vaccines (2023) Vol. 13, Iss. 02, pp. 13-32
Open Access | Times Cited: 1
Factors Associated with Humoral Immune Response Following the Third Dose of the BNT162b2 Received by Employees at a Health–Care Facility
Patrik Palacka, Alena Rajnochová Svobodová, Lucia Skokanová, et al.
(2023)
Open Access | Times Cited: 1
Anti- SARS-CoV-2 IgG and IgM Levels in Iraqi General Population
Amina Hamed Alobaidi, Hussein Inam Mustafa, Ahmed Mutar Salih, et al.
Anti-Inflammatory & Anti-Allergy Agents in Medicinal Chemistry (2023) Vol. 22, Iss. 2, pp. 113-129
Closed Access | Times Cited: 1
Coronavirus disease 2019 pandemic two years later… What’s next?
Rok Čivljak, Alemka Markotić
Croatian Medical Journal (2022) Vol. 63, Iss. 1, pp. 1-5
Open Access | Times Cited: 2
An Immune Response to Heterologous ChAdOx1/BNT162b2 Vaccination against COVID-19: Evaluation of the anti-RBD Specific IgG Antibodies Titers and Interferon Gamma Release Assay (IGRA) Test Results
Marzena Zalewska, Wiktoria Fus, Adam Konka, et al.
Vaccines (2022) Vol. 10, Iss. 9, pp. 1546-1546
Open Access | Times Cited: 2
Antibody Response (IgM and IgG) After Two Doses of Immunization Against SARS-CoV-2 and Comparison of Two Different Third Dose Administrations
İmran Sağlık, Melda Payaslıoğlu, Reyhan Başkılıç Aydın, et al.
Journal of Molecular Virology and Immunology (2023)
Open Access
Page 1 - Next Page

Scroll to top